Services

In-office Urine Drug Testing (UDT)

In-office (point-of-care) testing can be conducted with CLIA-waived instant-read devices, as well as instrumented devices (e.g. analyzers). These devices perform qualitative immunoassay tests only.

In-office urine drug test devices are used to provide health care professionals with immediate information, particularly on initial patient intake. While providing certain clinical value to the treating health care professional, these qualitative immunoassay tests identify the presence of a drug class, and a few specific drugs. The limitations of point-of-care testing, includingcutofflevels and known cross-reactivity, is important to consider. When it is clinically necessary to identify all specific drugs and illicit substances, laboratory quantization provide more comprehensive results for patient care decisions.

Laboratory Testing with LC-MS/MS Technology

Laboratory testing, such as liquid chromatography tandem mass-spectrometry (LC-MS/MS), is a more specific method, and returns a quantitative analytical result. These results provide precise identification of all drugs and metabolites present or absent. When used alone or in combination with qualitative immunoassay testing, LC-MS/MS testing can provide health care professionals with critical information to support patients’ overall treatment plans.

Laboratory testing by LC-MS/MS uses significantly lower cutoff levels than in-office drug tests and is, therefore, more accurate in determining medications and other substances present in, or absent from, a patient’s system at the time of the test.

LC-MS/MS and In-office Drug Test Cutoff Level* Comparison

Why is it important to monitor abuse and diversion of controlled substances while providing the right care for your pain patients? Pain medications are being abused all across the United States. Therefore, as a physician you must help abolish the trend while providing an effective treatment plan for your patients.

In this day and time, no patient should have to suffer by experiencing the unpleasant sensation of pain due to physician’s fear of prescribing controlled substances to well deserving patients.

To control abuse, physicians must monitor pain medications to ensure practice compliance. We provide you with an easy and efficient way to monitor compliance.

Millions of Americans are addicted to alcohol and drugs. In order to properly treat substance abuse, it is critical to identify the addiction and create a plan of action to combat it. Effective drug monitoring is crucial to formulate the right plan of care and take the first step to rehabilitation and prevent further disease and complications.

We offer a wide range of optional panel selection, giving you the tools you need to monitor and eliminate any type of substance abuse. We make it easy for you to test your patient population, receive results and handle any questions or concerns you may have. Our professional staff has years of experience and promises to exceed your expectations.

Together, we can control drug abuse in your practice and enhance the quality of care.

Don’t become a victim of preliminary findings delivered by point-of-care testing cups or bench top screens. These methods provides a fast turnaround, but not the accuracy or precision of an in-depth toxicology report available from liquid chromatography mass spectrometry (LC-MS/MS).

Many physicians don’t use point-of-care cups because they are unreliable and misleading.

Confirmation testing is the only reliable method that is 99.99% accurate and checks for metabolites as well as the parent drug.

Your quality of care depends directly on how well you monitor your practice and patient compliance in any treatment plan. Let us work for you to ensure practice compliance.

Why is it important to monitor abuse of controlled substances while providing the right care for your pain patients?

OB/GYN using drug screening as part of their daily routine are increasing across America. American Congress of Obstetricians and Gynecologists (ACOG) recommends physicians to test their patients for illicit drugs so they can seek help and reduce complications during pregnancy and delivery.

Drug and alcohol abuse have a direct correlation with obstetric and pediatric complications. Birth defects and developmental disabilities due to prenatal alcohol exposure can be easily prevented in the United States. If more women are tested for alcohol and drug abuse, they are more likely to take action to stop it.

It is a moral and ethical obligation on obstetricians to implement a protocol for drug screening in their practice. No child should have to suffer for a lifetime due to birth defects that could have been prevented by taking the neccesary steps of analyzing your patient’s urine or oral specimens for potentially harmful drugs.

If physicians are unaware of patient’s drug abuse, medical care can be jeopardized. For example, abrupt placenta separation may occur with acute cocaine use resulting in the harm of the mother and child. Women are less likely to take action or seek help if they are not screened and referred to a treatment facility or specialist.

You can make a positive difference in creating a safe environment for your expecting mothers and their unborn child by just adding a universal screening program to your practice.